According to a new research report Alzheimer’s Disease Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments” published by P&S Market Research, Alzheimer’s disease currently exhibits a pipeline with 89 active drug candidates.
Alzheimer’s disease pipeline offers novel therapeutic targets for the treatment of Alzheimer’s disease.
Download Sample of This Research Report: https://www.psmarketresearch.com/market-analysis/alzheimers-disease-pipeline-analysis/report-sample
The study analyzed that the Alzheimer’s disease pipeline comprises 89 drug candidates in different stages of development.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=alzheimers-disease-pipeline-analysis
Some of the key players developing drugs for Alzheimer’s disease are Eli Lilly and Company, Genentech, Inc., Eisai Co., Ltd., and others.
Alzheimer's Disease Pipeline Analysis
P&S Market Research offers customization as per specific business requirements of clients. Illustrative customization within the scope of this report includes:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886 (USA/Canada)